Observational Study
Copyright ©The Author(s) 2019.
World J Gastroenterol. Aug 14, 2019; 25(30): 4246-4260
Published online Aug 14, 2019. doi: 10.3748/wjg.v25.i30.4246
Figure 1
Figure 1 Forest plots showing the magnitude of difference ("Delta") between the rating of information domains given by profiles vs other participants. A, B, C, D, E and F stands for profiles 1, 2, 4, 7, 12 and 14, respectively. A: Patients with active disease [Manitona Inflammatory Bowel Diseases Index (MIBDI) A/B/C] and a history of hospitalization during the preceding 12 mo (n = 94); B: Patients with significantly active disease (MIBDI A/B/C) treated with immunomodulators and biologics (n = 52); C: Patients in remission while treated with mesalamine or receiving no treatment (n = 90); D: Patients older than age 50 years, diagnosed during the preceding 12 mo (n = 8); E: Patients who had surgery during the preceding 12 mo (n = 39); F: Patients diagnosed at age > 50 years (n = 72). Positive values indicate increased interest in the information domain, negative value indicates decreased interest. 1In which case data pertains to information needs at time of disease onset, presented data pertains to current information needs. MIBDI: Manitona Inflammatory Bowel Diseases Index.